NRG GU006

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Genitourinary, Prostate, Prostate Recurrent

Status:

Closed

A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or Without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer

NCT#03371719

NRG-GU006 permanently closed to accrual, effective May 19, 2020, because it has reached its accrual target.